nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—TOP2A—malignant glioma	0.662	1	CbGaD
Norfloxacin—CYP1A2—Carmustine—malignant glioma	0.113	0.569	CbGbCtD
Norfloxacin—CYP3A4—Temozolomide—malignant glioma	0.0852	0.43	CbGbCtD
Norfloxacin—Dysphasia—Temozolomide—malignant glioma	0.00528	0.0746	CcSEcCtD
Norfloxacin—Intracranial pressure increased—Carmustine—malignant glioma	0.00286	0.0404	CcSEcCtD
Norfloxacin—Trovafloxacin—TOP2A—malignant glioma	0.00194	0.237	CrCbGaD
Norfloxacin—Aphasia—Carmustine—malignant glioma	0.00184	0.026	CcSEcCtD
Norfloxacin—Aphasia—Temozolomide—malignant glioma	0.00178	0.0251	CcSEcCtD
Norfloxacin—Cholestasis—Temozolomide—malignant glioma	0.00152	0.0215	CcSEcCtD
Norfloxacin—Moxifloxacin—TOP2A—malignant glioma	0.00147	0.18	CrCbGaD
Norfloxacin—Hearing impaired—Temozolomide—malignant glioma	0.00121	0.0171	CcSEcCtD
Norfloxacin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00115	0.0163	CcSEcCtD
Norfloxacin—Pefloxacin—TOP2A—malignant glioma	0.00107	0.131	CrCbGaD
Norfloxacin—Enoxacin—TOP2A—malignant glioma	0.00101	0.123	CrCbGaD
Norfloxacin—Swelling—Carmustine—malignant glioma	0.000982	0.0139	CcSEcCtD
Norfloxacin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000963	0.0136	CcSEcCtD
Norfloxacin—Eye pain—Carmustine—malignant glioma	0.00096	0.0136	CcSEcCtD
Norfloxacin—Deafness—Temozolomide—malignant glioma	0.000936	0.0132	CcSEcCtD
Norfloxacin—Hepatic failure—Temozolomide—malignant glioma	0.000932	0.0132	CcSEcCtD
Norfloxacin—Eye pain—Temozolomide—malignant glioma	0.000927	0.0131	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000887	0.0125	CcSEcCtD
Norfloxacin—Diplopia—Carmustine—malignant glioma	0.000866	0.0122	CcSEcCtD
Norfloxacin—Diplopia—Temozolomide—malignant glioma	0.000837	0.0118	CcSEcCtD
Norfloxacin—Ataxia—Carmustine—malignant glioma	0.000815	0.0115	CcSEcCtD
Norfloxacin—Liver function test abnormal—Carmustine—malignant glioma	0.0008	0.0113	CcSEcCtD
Norfloxacin—Ataxia—Temozolomide—malignant glioma	0.000787	0.0111	CcSEcCtD
Norfloxacin—Lomefloxacin—TOP2A—malignant glioma	0.000762	0.093	CrCbGaD
Norfloxacin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000754	0.0107	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000754	0.0107	CcSEcCtD
Norfloxacin—Dysphagia—Carmustine—malignant glioma	0.000749	0.0106	CcSEcCtD
Norfloxacin—Dysphagia—Temozolomide—malignant glioma	0.000724	0.0102	CcSEcCtD
Norfloxacin—Neutropenia—Carmustine—malignant glioma	0.0007	0.00989	CcSEcCtD
Norfloxacin—Neutropenia—Temozolomide—malignant glioma	0.000677	0.00956	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Temozolomide—malignant glioma	0.000661	0.00933	CcSEcCtD
Norfloxacin—Renal failure—Carmustine—malignant glioma	0.000656	0.00927	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Carmustine—malignant glioma	0.000655	0.00925	CcSEcCtD
Norfloxacin—Levofloxacin—TOP2A—malignant glioma	0.000651	0.0795	CrCbGaD
Norfloxacin—Ofloxacin—TOP2A—malignant glioma	0.000651	0.0795	CrCbGaD
Norfloxacin—Stomatitis—Carmustine—malignant glioma	0.000651	0.0092	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00064	0.00904	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Temozolomide—malignant glioma	0.000633	0.00894	CcSEcCtD
Norfloxacin—Stomatitis—Temozolomide—malignant glioma	0.000629	0.00889	CcSEcCtD
Norfloxacin—Ciprofloxacin—TOP2A—malignant glioma	0.000629	0.0768	CrCbGaD
Norfloxacin—Hallucination—Carmustine—malignant glioma	0.000596	0.00843	CcSEcCtD
Norfloxacin—Hypoaesthesia—Carmustine—malignant glioma	0.000596	0.00843	CcSEcCtD
Norfloxacin—Hepatitis—Temozolomide—malignant glioma	0.000579	0.00818	CcSEcCtD
Norfloxacin—Visual impairment—Carmustine—malignant glioma	0.000578	0.00816	CcSEcCtD
Norfloxacin—Hypoaesthesia—Temozolomide—malignant glioma	0.000576	0.00814	CcSEcCtD
Norfloxacin—Hallucination—Temozolomide—malignant glioma	0.000576	0.00814	CcSEcCtD
Norfloxacin—Visual impairment—Temozolomide—malignant glioma	0.000558	0.00789	CcSEcCtD
Norfloxacin—Erythema multiforme—Temozolomide—malignant glioma	0.000548	0.00774	CcSEcCtD
Norfloxacin—Tinnitus—Temozolomide—malignant glioma	0.00054	0.00763	CcSEcCtD
Norfloxacin—Erythema—Carmustine—malignant glioma	0.000522	0.00737	CcSEcCtD
Norfloxacin—Chills—Temozolomide—malignant glioma	0.00052	0.00734	CcSEcCtD
Norfloxacin—Back pain—Carmustine—malignant glioma	0.000505	0.00713	CcSEcCtD
Norfloxacin—Erythema—Temozolomide—malignant glioma	0.000504	0.00712	CcSEcCtD
Norfloxacin—Dysgeusia—Temozolomide—malignant glioma	0.000494	0.00698	CcSEcCtD
Norfloxacin—Vision blurred—Carmustine—malignant glioma	0.000492	0.00695	CcSEcCtD
Norfloxacin—Tremor—Carmustine—malignant glioma	0.000489	0.00691	CcSEcCtD
Norfloxacin—Back pain—Temozolomide—malignant glioma	0.000488	0.00689	CcSEcCtD
Norfloxacin—Agitation—Carmustine—malignant glioma	0.00048	0.00678	CcSEcCtD
Norfloxacin—Vision blurred—Temozolomide—malignant glioma	0.000475	0.00671	CcSEcCtD
Norfloxacin—Tremor—Temozolomide—malignant glioma	0.000472	0.00667	CcSEcCtD
Norfloxacin—Leukopenia—Carmustine—malignant glioma	0.000467	0.0066	CcSEcCtD
Norfloxacin—Agitation—Temozolomide—malignant glioma	0.000463	0.00655	CcSEcCtD
Norfloxacin—Angioedema—Temozolomide—malignant glioma	0.000461	0.00651	CcSEcCtD
Norfloxacin—Vertigo—Temozolomide—malignant glioma	0.000453	0.0064	CcSEcCtD
Norfloxacin—Convulsion—Carmustine—malignant glioma	0.000452	0.00639	CcSEcCtD
Norfloxacin—Leukopenia—Temozolomide—malignant glioma	0.000451	0.00638	CcSEcCtD
Norfloxacin—Palpitations—Temozolomide—malignant glioma	0.000446	0.0063	CcSEcCtD
Norfloxacin—Chest pain—Carmustine—malignant glioma	0.000444	0.00628	CcSEcCtD
Norfloxacin—Myalgia—Carmustine—malignant glioma	0.000444	0.00628	CcSEcCtD
Norfloxacin—Anxiety—Carmustine—malignant glioma	0.000443	0.00625	CcSEcCtD
Norfloxacin—Convulsion—Temozolomide—malignant glioma	0.000437	0.00617	CcSEcCtD
Norfloxacin—Confusional state—Carmustine—malignant glioma	0.000429	0.00607	CcSEcCtD
Norfloxacin—Myalgia—Temozolomide—malignant glioma	0.000429	0.00607	CcSEcCtD
Norfloxacin—Arthralgia—Temozolomide—malignant glioma	0.000429	0.00607	CcSEcCtD
Norfloxacin—Anxiety—Temozolomide—malignant glioma	0.000428	0.00604	CcSEcCtD
Norfloxacin—Oedema—Carmustine—malignant glioma	0.000426	0.00602	CcSEcCtD
Norfloxacin—Dry mouth—Temozolomide—malignant glioma	0.00042	0.00593	CcSEcCtD
Norfloxacin—Thrombocytopenia—Carmustine—malignant glioma	0.000417	0.00589	CcSEcCtD
Norfloxacin—Confusional state—Temozolomide—malignant glioma	0.000415	0.00586	CcSEcCtD
Norfloxacin—Oedema—Temozolomide—malignant glioma	0.000412	0.00581	CcSEcCtD
Norfloxacin—Anaphylactic shock—Temozolomide—malignant glioma	0.000412	0.00581	CcSEcCtD
Norfloxacin—Anorexia—Carmustine—malignant glioma	0.000406	0.00574	CcSEcCtD
Norfloxacin—Thrombocytopenia—Temozolomide—malignant glioma	0.000403	0.00569	CcSEcCtD
Norfloxacin—Hyperhidrosis—Temozolomide—malignant glioma	0.000398	0.00562	CcSEcCtD
Norfloxacin—Anorexia—Temozolomide—malignant glioma	0.000392	0.00554	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000388	0.00548	CcSEcCtD
Norfloxacin—Insomnia—Carmustine—malignant glioma	0.000385	0.00544	CcSEcCtD
Norfloxacin—Paraesthesia—Carmustine—malignant glioma	0.000382	0.0054	CcSEcCtD
Norfloxacin—Dyspnoea—Carmustine—malignant glioma	0.00038	0.00536	CcSEcCtD
Norfloxacin—Somnolence—Carmustine—malignant glioma	0.000379	0.00535	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000375	0.0053	CcSEcCtD
Norfloxacin—Insomnia—Temozolomide—malignant glioma	0.000372	0.00526	CcSEcCtD
Norfloxacin—Decreased appetite—Carmustine—malignant glioma	0.00037	0.00523	CcSEcCtD
Norfloxacin—Paraesthesia—Temozolomide—malignant glioma	0.00037	0.00522	CcSEcCtD
Norfloxacin—Dyspnoea—Temozolomide—malignant glioma	0.000367	0.00518	CcSEcCtD
Norfloxacin—Somnolence—Temozolomide—malignant glioma	0.000366	0.00517	CcSEcCtD
Norfloxacin—Constipation—Carmustine—malignant glioma	0.000364	0.00515	CcSEcCtD
Norfloxacin—Dyspepsia—Temozolomide—malignant glioma	0.000362	0.00512	CcSEcCtD
Norfloxacin—Decreased appetite—Temozolomide—malignant glioma	0.000358	0.00505	CcSEcCtD
Norfloxacin—Fatigue—Temozolomide—malignant glioma	0.000355	0.00501	CcSEcCtD
Norfloxacin—Constipation—Temozolomide—malignant glioma	0.000352	0.00497	CcSEcCtD
Norfloxacin—Feeling abnormal—Carmustine—malignant glioma	0.000351	0.00496	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Carmustine—malignant glioma	0.000348	0.00492	CcSEcCtD
Norfloxacin—Feeling abnormal—Temozolomide—malignant glioma	0.000339	0.00479	CcSEcCtD
Norfloxacin—Abdominal pain—Carmustine—malignant glioma	0.000337	0.00476	CcSEcCtD
Norfloxacin—Body temperature increased—Carmustine—malignant glioma	0.000337	0.00476	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000337	0.00475	CcSEcCtD
Norfloxacin—Urticaria—Temozolomide—malignant glioma	0.000327	0.00462	CcSEcCtD
Norfloxacin—Abdominal pain—Temozolomide—malignant glioma	0.000325	0.0046	CcSEcCtD
Norfloxacin—Body temperature increased—Temozolomide—malignant glioma	0.000325	0.0046	CcSEcCtD
Norfloxacin—Hypersensitivity—Carmustine—malignant glioma	0.000314	0.00443	CcSEcCtD
Norfloxacin—Asthenia—Carmustine—malignant glioma	0.000306	0.00432	CcSEcCtD
Norfloxacin—Hypersensitivity—Temozolomide—malignant glioma	0.000303	0.00428	CcSEcCtD
Norfloxacin—Asthenia—Temozolomide—malignant glioma	0.000295	0.00417	CcSEcCtD
Norfloxacin—Diarrhoea—Carmustine—malignant glioma	0.000291	0.00412	CcSEcCtD
Norfloxacin—Pruritus—Temozolomide—malignant glioma	0.000291	0.00411	CcSEcCtD
Norfloxacin—Dizziness—Carmustine—malignant glioma	0.000282	0.00398	CcSEcCtD
Norfloxacin—Diarrhoea—Temozolomide—malignant glioma	0.000282	0.00398	CcSEcCtD
Norfloxacin—Dizziness—Temozolomide—malignant glioma	0.000272	0.00385	CcSEcCtD
Norfloxacin—Vomiting—Carmustine—malignant glioma	0.000271	0.00383	CcSEcCtD
Norfloxacin—Rash—Carmustine—malignant glioma	0.000269	0.00379	CcSEcCtD
Norfloxacin—Dermatitis—Carmustine—malignant glioma	0.000268	0.00379	CcSEcCtD
Norfloxacin—Headache—Carmustine—malignant glioma	0.000267	0.00377	CcSEcCtD
Norfloxacin—Vomiting—Temozolomide—malignant glioma	0.000262	0.0037	CcSEcCtD
Norfloxacin—Rash—Temozolomide—malignant glioma	0.000259	0.00367	CcSEcCtD
Norfloxacin—Dermatitis—Temozolomide—malignant glioma	0.000259	0.00366	CcSEcCtD
Norfloxacin—Headache—Temozolomide—malignant glioma	0.000258	0.00364	CcSEcCtD
Norfloxacin—Nausea—Carmustine—malignant glioma	0.000253	0.00357	CcSEcCtD
Norfloxacin—Nausea—Temozolomide—malignant glioma	0.000244	0.00345	CcSEcCtD
Norfloxacin—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	6.95e-05	0.00114	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	6.85e-05	0.00112	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—malignant glioma	6.75e-05	0.0011	CbGpPWpGaD
Norfloxacin—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	6.66e-05	0.00109	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—malignant glioma	6.59e-05	0.00108	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	6.55e-05	0.00107	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—RTEL1—malignant glioma	6.54e-05	0.00107	CbGpPWpGaD
Norfloxacin—CYP3A5—Biological oxidations—GSTP1—malignant glioma	6.46e-05	0.00106	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	6.44e-05	0.00105	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	6.44e-05	0.00105	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.43e-05	0.00105	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—malignant glioma	6.39e-05	0.00104	CbGpPWpGaD
Norfloxacin—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	6.38e-05	0.00104	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	6.18e-05	0.00101	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—RTEL1—malignant glioma	6.17e-05	0.00101	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	6.15e-05	0.00101	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	6.13e-05	0.001	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—malignant glioma	6.13e-05	0.001	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.12e-05	0.001	CbGpPWpGaD
Norfloxacin—CYP1A1—Biological oxidations—GSTP1—malignant glioma	6.11e-05	0.000998	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	6.1e-05	0.000997	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	6.09e-05	0.000995	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	6.04e-05	0.000988	CbGpPWpGaD
Norfloxacin—CYP1A1—Metapathway biotransformation—GSTP1—malignant glioma	6.02e-05	0.000985	CbGpPWpGaD
Norfloxacin—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	6.01e-05	0.000982	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	5.99e-05	0.000979	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—PTEN—malignant glioma	5.91e-05	0.000966	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	5.79e-05	0.000947	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—BRCA2—malignant glioma	5.76e-05	0.000942	CbGpPWpGaD
Norfloxacin—CYP1A1—PPARA activates gene expression—PPARG—malignant glioma	5.75e-05	0.00094	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN2B—malignant glioma	5.71e-05	0.000934	CbGpPWpGaD
Norfloxacin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—malignant glioma	5.63e-05	0.00092	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—GSTT1—malignant glioma	5.62e-05	0.000918	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	5.56e-05	0.000909	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—malignant glioma	5.51e-05	0.000901	CbGpPWpGaD
Norfloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	5.42e-05	0.000886	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—malignant glioma	5.41e-05	0.000885	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	5.39e-05	0.000881	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	5.37e-05	0.000878	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	5.36e-05	0.000876	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	5.29e-05	0.000864	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—TFRC—malignant glioma	5.29e-05	0.000864	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—PTGS1—malignant glioma	5.26e-05	0.00086	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—COX8A—malignant glioma	5.19e-05	0.000849	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	5.11e-05	0.000836	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	5e-05	0.000818	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—BIRC5—malignant glioma	4.93e-05	0.000806	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	4.85e-05	0.000794	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TERT—malignant glioma	4.78e-05	0.000781	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	4.76e-05	0.000779	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—COX8A—malignant glioma	4.76e-05	0.000778	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	4.73e-05	0.000772	CbGpPWpGaD
Norfloxacin—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	4.64e-05	0.000758	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	4.62e-05	0.000755	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	4.56e-05	0.000746	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ASMT—malignant glioma	4.42e-05	0.000722	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.41e-05	0.000721	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	4.34e-05	0.00071	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTT1—malignant glioma	4.34e-05	0.000709	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.27e-05	0.000698	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	4.2e-05	0.000687	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	4.2e-05	0.000686	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—BCAN—malignant glioma	4.15e-05	0.000679	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	4.11e-05	0.000671	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	4.11e-05	0.000671	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—PTGS1—malignant glioma	4.06e-05	0.000664	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ASMT—malignant glioma	4.05e-05	0.000662	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—TP53—malignant glioma	4.03e-05	0.000659	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—RTEL1—malignant glioma	3.94e-05	0.000644	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	3.91e-05	0.000639	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	3.91e-05	0.000639	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—GSTP1—malignant glioma	3.89e-05	0.000636	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	3.88e-05	0.000634	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—malignant glioma	3.88e-05	0.000634	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	3.84e-05	0.000628	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—BCAN—malignant glioma	3.81e-05	0.000622	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—COX8A—malignant glioma	3.75e-05	0.000614	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—malignant glioma	3.65e-05	0.000597	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.55e-05	0.00058	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—COX8A—malignant glioma	3.55e-05	0.00058	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—IDH2—malignant glioma	3.35e-05	0.000547	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN2A—malignant glioma	3.27e-05	0.000534	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ASMT—malignant glioma	3.19e-05	0.000522	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.17e-05	0.000518	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MDM2—malignant glioma	3.17e-05	0.000518	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP2B6—malignant glioma	3.15e-05	0.000514	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—IDH2—malignant glioma	3.07e-05	0.000501	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—RTEL1—malignant glioma	3.04e-05	0.000497	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ASMT—malignant glioma	3.02e-05	0.000493	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.01e-05	0.000491	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—BCAN—malignant glioma	3e-05	0.000491	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	2.96e-05	0.000484	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.95e-05	0.000482	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP2B6—malignant glioma	2.88e-05	0.000471	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—IDH1—malignant glioma	2.88e-05	0.00047	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—BCAN—malignant glioma	2.84e-05	0.000463	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	2.81e-05	0.00046	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SPHK1—malignant glioma	2.78e-05	0.000455	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—malignant glioma	2.77e-05	0.000454	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP2C18—malignant glioma	2.73e-05	0.000446	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.72e-05	0.000445	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—IDH1—malignant glioma	2.64e-05	0.000431	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SPHK1—malignant glioma	2.55e-05	0.000417	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP2C18—malignant glioma	2.5e-05	0.000409	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—malignant glioma	2.48e-05	0.000405	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—IDH2—malignant glioma	2.42e-05	0.000395	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—IDH2—malignant glioma	2.29e-05	0.000374	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP2B6—malignant glioma	2.27e-05	0.000372	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—COX8A—malignant glioma	2.26e-05	0.00037	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MYC—malignant glioma	2.21e-05	0.000362	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTT1—malignant glioma	2.21e-05	0.000361	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.15e-05	0.000352	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP2B6—malignant glioma	2.15e-05	0.000351	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	2.09e-05	0.000342	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—IDH1—malignant glioma	2.08e-05	0.00034	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS1—malignant glioma	2.07e-05	0.000338	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTT1—malignant glioma	2.02e-05	0.000331	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.02e-05	0.00033	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SPHK1—malignant glioma	2.01e-05	0.000329	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP2C18—malignant glioma	1.97e-05	0.000322	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—IDH1—malignant glioma	1.97e-05	0.000321	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ASMT—malignant glioma	1.92e-05	0.000314	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—BCHE—malignant glioma	1.92e-05	0.000314	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SPHK1—malignant glioma	1.9e-05	0.000311	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SLC5A5—malignant glioma	1.9e-05	0.00031	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS1—malignant glioma	1.89e-05	0.00031	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.88e-05	0.000307	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP2C18—malignant glioma	1.86e-05	0.000305	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TP53—malignant glioma	1.82e-05	0.000297	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—BCAN—malignant glioma	1.81e-05	0.000295	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—BCHE—malignant glioma	1.76e-05	0.000288	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.76e-05	0.000287	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—COX8A—malignant glioma	1.75e-05	0.000285	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SLC5A5—malignant glioma	1.74e-05	0.000284	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.6e-05	0.000262	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTT1—malignant glioma	1.59e-05	0.000261	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.54e-05	0.000252	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTP1—malignant glioma	1.53e-05	0.00025	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTT1—malignant glioma	1.51e-05	0.000246	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS1—malignant glioma	1.49e-05	0.000244	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CAT—malignant glioma	1.49e-05	0.000243	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ASMT—malignant glioma	1.48e-05	0.000243	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—IDH2—malignant glioma	1.46e-05	0.000238	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS1—malignant glioma	1.41e-05	0.000231	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.41e-05	0.00023	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NCOR1—malignant glioma	1.41e-05	0.00023	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTP1—malignant glioma	1.4e-05	0.000229	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—BCAN—malignant glioma	1.4e-05	0.000228	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—BCHE—malignant glioma	1.39e-05	0.000227	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.37e-05	0.000225	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.37e-05	0.000224	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.37e-05	0.000224	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CAT—malignant glioma	1.36e-05	0.000223	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—BCHE—malignant glioma	1.31e-05	0.000215	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC5A5—malignant glioma	1.3e-05	0.000212	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NCOR1—malignant glioma	1.29e-05	0.000211	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—IDH1—malignant glioma	1.25e-05	0.000205	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.23e-05	0.0002	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.21e-05	0.000199	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SPHK1—malignant glioma	1.21e-05	0.000198	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.19e-05	0.000194	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CAV1—malignant glioma	1.15e-05	0.000187	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—IDH2—malignant glioma	1.12e-05	0.000184	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.12e-05	0.000183	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTP1—malignant glioma	1.11e-05	0.000181	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CAT—malignant glioma	1.08e-05	0.000176	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.06e-05	0.000173	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.06e-05	0.000173	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CAV1—malignant glioma	1.05e-05	0.000172	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTP1—malignant glioma	1.04e-05	0.000171	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CG—malignant glioma	1.04e-05	0.000171	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.02e-05	0.000167	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CAT—malignant glioma	1.02e-05	0.000166	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NCOR1—malignant glioma	1.02e-05	0.000166	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPARG—malignant glioma	1.01e-05	0.000165	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.85e-06	0.000161	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—IDH1—malignant glioma	9.67e-06	0.000158	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTT1—malignant glioma	9.61e-06	0.000157	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NCOR1—malignant glioma	9.6e-06	0.000157	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CG—malignant glioma	9.56e-06	0.000156	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SPHK1—malignant glioma	9.36e-06	0.000153	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPARG—malignant glioma	9.23e-06	0.000151	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CD—malignant glioma	9.17e-06	0.00015	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.17e-06	0.00015	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS1—malignant glioma	9e-06	0.000147	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.97e-06	0.000147	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CD—malignant glioma	8.41e-06	0.000137	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—BCHE—malignant glioma	8.37e-06	0.000137	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CAV1—malignant glioma	8.28e-06	0.000135	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC5A5—malignant glioma	8.27e-06	0.000135	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CB—malignant glioma	8e-06	0.000131	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS2—malignant glioma	7.92e-06	0.00013	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CAV1—malignant glioma	7.82e-06	0.000128	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.82e-06	0.000128	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.75e-06	0.000127	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CG—malignant glioma	7.54e-06	0.000123	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.47e-06	0.000122	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTT1—malignant glioma	7.41e-06	0.000121	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CB—malignant glioma	7.33e-06	0.00012	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPARG—malignant glioma	7.28e-06	0.000119	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS2—malignant glioma	7.26e-06	0.000119	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CG—malignant glioma	7.13e-06	0.000116	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS1—malignant glioma	6.95e-06	0.000114	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTEN—malignant glioma	6.91e-06	0.000113	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPARG—malignant glioma	6.88e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.76e-06	0.00011	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTP1—malignant glioma	6.66e-06	0.000109	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CD—malignant glioma	6.63e-06	0.000108	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CAT—malignant glioma	6.48e-06	0.000106	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—BCHE—malignant glioma	6.46e-06	0.000106	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.38e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTEN—malignant glioma	6.33e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CD—malignant glioma	6.26e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NCOR1—malignant glioma	6.12e-06	0.0001	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CB—malignant glioma	5.78e-06	9.45e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS2—malignant glioma	5.73e-06	9.36e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CB—malignant glioma	5.46e-06	8.93e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS2—malignant glioma	5.41e-06	8.84e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTP1—malignant glioma	5.14e-06	8.4e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CAT—malignant glioma	5e-06	8.17e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTEN—malignant glioma	4.99e-06	8.16e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CAV1—malignant glioma	4.99e-06	8.15e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CA—malignant glioma	4.87e-06	7.97e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.77e-06	7.79e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NCOR1—malignant glioma	4.72e-06	7.72e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTEN—malignant glioma	4.72e-06	7.71e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.54e-06	7.43e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CA—malignant glioma	4.47e-06	7.3e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPARG—malignant glioma	4.39e-06	7.17e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.99e-06	6.53e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AKT1—malignant glioma	3.98e-06	6.51e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CAV1—malignant glioma	3.85e-06	6.29e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AKT1—malignant glioma	3.65e-06	5.97e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.52e-06	5.76e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.51e-06	5.73e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.48e-06	5.69e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS2—malignant glioma	3.45e-06	5.64e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPARG—malignant glioma	3.38e-06	5.53e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CA—malignant glioma	3.33e-06	5.44e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.08e-06	5.04e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTEN—malignant glioma	3.01e-06	4.92e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AKT1—malignant glioma	2.88e-06	4.7e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AKT1—malignant glioma	2.72e-06	4.44e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.69e-06	4.39e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS2—malignant glioma	2.66e-06	4.35e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTEN—malignant glioma	2.32e-06	3.8e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.12e-06	3.47e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AKT1—malignant glioma	1.73e-06	2.83e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.64e-06	2.68e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AKT1—malignant glioma	1.34e-06	2.19e-05	CbGpPWpGaD
